Exelixis (EXEL) Tops Q1 EPS by 6c, Beat on Revenues
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $50.61 +0.46%
Financial Fact:
Total operating expenses: 61.39M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Total operating expenses: 61.39M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.05, $0.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $80.9 million versus the consensus estimate of $65.23 million.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
- KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
